These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10783897)

  • 1. Georgia realizes the commercial potential of science.
    Horton B
    Nature; 2000 Apr; 404(6779):794. PubMed ID: 10783897
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology transfer and idea commercialization.
    Sheft J
    Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
    [No Abstract]   [Full Text] [Related]  

  • 3. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 4. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 5. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 6. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 7. Universities, business, and the state government: partners in progress.
    Edlich RF
    J Emerg Med; 1992; 10(5):617-21. PubMed ID: 1401866
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
    Fernandes M; Miska D
    Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the university-industrial complex out of control?
    Nature; 2001 Jan; 409(6817):119. PubMed ID: 11196604
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivering beneficial impacts in Assistive Technology: Improving government's approach to innovation.
    Lane JP
    Stud Health Technol Inform; 2015; 217():78-83. PubMed ID: 26294456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Georgia on the mind.
    Smaglik P
    Nature; 2007 Feb; 445(7129):790-1. PubMed ID: 17340677
    [No Abstract]   [Full Text] [Related]  

  • 12. Faculty start-ups offer temptation to breach academic rules . . . but Syngenta deal is a boon to Berkeley.
    Metz M
    Nature; 2001 Mar; 410(6828):513. PubMed ID: 11279462
    [No Abstract]   [Full Text] [Related]  

  • 13. Curiosity makes way for capitalism.
    Cyranoski D
    Nature; 2004 May; 429(6988):216-9. PubMed ID: 15141220
    [No Abstract]   [Full Text] [Related]  

  • 14. Japanese national universities are now 'incorporated'.
    Kandachi K
    Nat Biotechnol; 2004 May; 22(5):623-4. PubMed ID: 15146870
    [No Abstract]   [Full Text] [Related]  

  • 15. Material transfer agreements: open science vs. proprietary claims.
    Rodriguez V
    Nat Biotechnol; 2005 Apr; 23(4):489-91. PubMed ID: 15815676
    [No Abstract]   [Full Text] [Related]  

  • 16. Patents and the research exemption.
    Resnik DB
    Science; 2003 Feb; 299(5608):821-2. PubMed ID: 12574602
    [No Abstract]   [Full Text] [Related]  

  • 17. Humboldt hopes.
    Gross M
    Curr Biol; 2008 Oct; 18(20):R937. PubMed ID: 18983951
    [No Abstract]   [Full Text] [Related]  

  • 18. Faculty start-ups offer temptation to breach academic rules.
    Koehn RK
    Nature; 2001 Mar; 410(6828):513. PubMed ID: 11279461
    [No Abstract]   [Full Text] [Related]  

  • 19. Asia calls for united approach to commerce.
    Saegusa A
    Nat Biotechnol; 1999 Oct; 17(10):946-7. PubMed ID: 10504685
    [No Abstract]   [Full Text] [Related]  

  • 20. Interdisciplinary science: Harvard under review.
    Lok C
    Nature; 2008 Aug; 454(7205):686-9. PubMed ID: 18685675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.